Metal-On-Metal Hip Post-market Studies Behind Schedule, NEJM Article Highlights
This article was originally published in The Gray Sheet
Executive Summary
Delays in getting FDA-ordered surveillance studies up and running for hip implants should be addressed at an advisory panel this week, researchers from the Pew Health Group and Cornell argue.
You may also be interested in...
FDA '522' Guidance: 15-Month Deadline To Comply With Postmarket Order
The agency has issued a final guidance on Sec. 522 postmarket study orders about five years after a draft version. In the interim, Congress stipulated a 15-month deadline for companies to start the FDA-mandated studies, a requirement emphasized in the new document.
Data Questions Dominate Metal-On-Metal Panel; New Monitoring Recommended
FDA advisory panel examines science behind controversial metal-on-metal hips, recommends new monitoring, possible label changes.
House Passes Compromise User Fee Bill; Senate To Vote This Week
The final bill includes device user fee reauthorization and additional FDA reforms, including a streamlined device reclassification process that has some in the device industry nervous.